血脳障壁の形成と機能障害
Zhen Zhao1, Amy R Nelson1, Christer Betsholtz2
1Department of Physiology and Biophysics and the Zilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90089, USA.
Cell
|November 23, 2015
まとめ
この研究は,血脳障壁 (BBB) の形成と維持の方法を調べています. BBB機能障害は アルツハイマー病のような 神経疾患と関連しています
科学分野:
- 神経科学
- 細胞生物学
- 生理学
背景:
- 脳の機能は 神経血管単位内の 協調した信号に依存しています
- 血脳障壁 (BBB) は,シナプス活動と情報処理に不可欠です.
研究 の 目的:
- 血脳障壁 (BBB) の形成と維持を制御するメカニズムを調査する.
- BBBに関連した細胞の役割を探るため
- BBBの崩壊と神経疾患の関連を検証する.
主な方法:
- BBB形成と維持メカニズムに関する文献レビュー.
- 神経血管ユニット内の細胞相互作用の分析
- BBB機能障害と神経学的障害を関連付ける証拠の検討
主要な成果:
- BBBの整合性は 適切な脳信号と機能に不可欠です
- 特定の細胞メカニズムは BBB の発達と維持を制御します
- BBBの崩壊は様々な神経学的状態にますます関与しています.
結論:
- BBBの規制を理解することは 神経疾患の治療の鍵です
- BBBの機能障害をターゲットにすることで アルツハイマー病のような疾患の 治療戦略を提供できます
関連する概念動画
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Small interfering RNAs (siRNA)
4.3K
No description available
4.3K
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Hepatic Drug Excretion: Influencing Factors
539
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539